Last updated: February 17, 2021
Sponsor: Elisa Della Casa Muttini
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT04759573
Early Vocal Contact
Ages 25-33 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- • GA between 25+0 and 32 +6 weeks at birth
- Apgar score: ≥ 7 at 10 minutes
- Birth weight: >3th centile and <97th centile
- Birth cranial circumference: >10th centile
- Periventricular leukomalacia (PVL) grade 1
- Intraventricular haemorrhage (IVH) grade 1-2
- Hypoglycaemia
- Hyponatremia acceptable, provided they are not persistent and severe
- Hypocalcaemia
Exclusion
Exclusion Criteria:
- • PVL, grade III and IV
- IVH, grade III and IV
- Sepsis (vertical and horizontal)
- Congenital malformations and/or genetic abnormalities
- Need of respiratory support with high flow/nCPAP
- Repeated apnoea associated with bradycardia and fall of saturation
- Hyaline membrane disease
- Respiratory Distress Syndrome
- Hyperbilirubinemia, requiring exchange transfusions during hospitalization
- Lack of informed consent signed by the parents The exclusion criteria for the mothers will be:
- Presence of depressive symptoms
- Drug abuse
- Age ˂18 years
Study Design
Total Participants: 80
Study Start date:
February 01, 2019
Estimated Completion Date:
June 01, 2024
Study Description
Connect with a study center
Uiversity Hospital of Modena and Reggio Emilia
Modena, 41100
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.